Abstract View

Author(s): Rahil Salim Meman1*1, Furkhan Khan Younus Khan22

Email(s): 1memon.rahil99@gmail.com

Address:

    1 Department of Pharmaceutics, Ismail Mehta College of Pharmacy, Ambad. 2 Department of Pharmacology, Ismail Mehta College of Pharmacy, Ambad.

Published In:   Volume - 5,      Issue - 2,     Year - 2026

DOI: https://doi.org/10.71431/IJRPAS.2026.5202  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
The scarcity of compatible blood for transfusion remains a critical challenge in emergency medicine, particularly in trauma, surgical, and battlefield scenarios[1]. Plastic blood, or synthetic blood substitutes, represent a transformative advancement in addressing this global shortage. These engineered solutions utilize hemoglobin-based oxygen carriers (HBOCs) and perfluorocarbon products to provide immediate oxygen delivery without requiring blood typing or compatibility testing[2]. This research paper examines the current state of plastic blood technology, including its composition, mechanisms of action, clinical applications, advantages over traditional blood transfusions, and ongoing challenges in achieving widespread clinical implementation.

Cite this article:
Rahil Salim Meman, Furkhan Khan Younus Khan. Plastic Blood: Synthetic Blood Substitutes in Emergency Medicine for Patient Transfusion. IJRPAS, February 2026; 5(2): 11-19.DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2026.5202


1.    NHLBI. (2024). Potential game-changer for emergency medicine: Synthetic platelets. National Institutes of Health. https://www.nhlbi.nih.gov/news/2024/potential-game-changer-emergency-medicine-synthetic-platelets

2.    NIH/PMC. (2024). Artificial blood for therapeutic and laboratory usage. PubMed Central, 11427025. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11427025/

3.    NIH/PMC. (1999). Blood substitutes: Haemoglobin therapeutics in clinical use. Transfusion Medicine Reviews, 13(4), 1-25. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC137240/

4.    NIH/PMC. (2020). Artificial blood: The history and current perspectives of hemoglobin-based oxygen carriers. Frontiers in Medicine, 7, 86. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC7086064/

5.    Science Magazine. (2024, July 2). The ultimate blood substitute? The U.S. military is betting $46 million. Science, 385(6), 245-248. https://www.science.org/content/article/ultimate-blood-substitute-us-military-betting-46-million

6.    NPR. (2025, July 24). Scientists are developing artificial blood that could save lives. Shots - Health News. https://www.npr.org/sections/shots-health-news/2025/07/24/nx-s1-5477632/artificial-blood-hemorrhage-emergency-medicine

7.    NIH/PMC. (2018). Artificial blood: A futuristic dimension of modern day transfusion medicine. Journal of Laboratory Medicine, 42(6), 234-245. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC6864588/

8.    ASH Clinical News. (2025, February 19). Banking on artificial blood. American Society of Hematology Clinical News. https://ashpublications.org/ashclinicalnews/news/8465/Banking-on-Artificial-Blood

9.    Al Jazeera. (2025, March 8). How close are scientists to producing artificial blood? Retrieved from https://www.aljazeera.com/news/2025/3/8/how-close-are-scientists-to-producing-artificial-blood

Related Images:



Recent Images



Assessing Philippine Health Care Coverage Gaps: An Assessment of Accessibility of Public Health Programs in Selected Barangay in Imus, Cavite, Philippines
Isoabsorptive UV Spectrophotometry Method development and validation for simultaneous estimation of Eslicarbazepine Acetate and Carbamazepine
To develop and validate the stability indicating method for repaglinide and voglibose using HPLC method
To develop and validate the stability indicating method for Empagliflozin and Linagliptin using HPLC method
A Prospective Observational Study on the Clinical Evaluation of Vertigoin Young Adult Population of Amaravati Capital Region
Quality by Design-Based Analytical Method Development and Validation of Suzetrigine by RP - HPLC
Formulation, Optimization and Evaluation of Rimegepant Pulsatile Tablets for Chronotherapeutic Management of Migraine
Development and Evaluation of Ticagrelor Solid Dispersion Tablets Using PVP K30, PEG 6000 and HPMC E5 for Dissolution Enhancement
To study the effect of various superdisintegrants and binders in the Formulation and Evaluation of Labetalol Rapid Disintegrating Tablet
To Develop and Validate the Stability Indicating Method for Ezetimibe and Rosuvastatin Using HPLC Method

Tags